News
Despite Ozempic being the most recognisable brand name, as far as the people prescribing it are concerned weight loss is ...
Lars Fruergaard Jørgensen, the boss of Danish pharmaceutical giant Novo Nordisk, explained what impact the drugs can have on users weight in the long run ...
We recently published an article titled These 10 Stocks Moved the Market This Week, Here’s Why. In this article, we are going ...
Nordics for Climate Action, a collaborative initiative of the consulates general of Denmark, Finland, and Norway in Shanghai, ...
Although the Mississippi Delta has abundant farmland, there are gaps in what the region produces and what ends up on the ...
Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results